COPENHAGEN (Reuters) -Novo Nordisk said on Monday it would lower the U. price of its injectable Wegovy obesity drug and pledged to go "all in" on its upcoming oral weight-loss pill,​ as the firm races to claw back lost ground in the lucrative market.

Bibendum non. Nam vitae libero mauris. Suspendisse vitae purus ligula. Morbi sed diam eget dolor posuere convallis vel nisl. Nulla sagittis efficitur ex, at sodales massa pulvinar a. Nunc quis lacinia eros. Fusce ac ipsum gravida, tristique sed felis augue decree nec consectetuer quis. Elementum eu arcu nunc ornare aarcu lacus quis. Aliquet odio.

Maxwell Kruzic said he was in such “crippling” stomach pain Oct. 5, 2023, that he had to pull off the road twice as he drove himself to the emergency room at Mercy Regional Medical Center in Durango, Colorado. “It was the worst pain of my life,” he said. Kruzic was seen immediately because hospital staff members were pretty sure he had appendicitis. They inserted an IV, called a surgeon and sent him off for a scan to confirm the diagnosis.Subscribe to The Post Most newsletter for the most import